Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Boehringer Ingelheim To Commence Phase III Study Investigating BIBW 2992 As Treatment For Non-Small Cell Lung Cancer Patients With EGFR Mutations
Boehringer Ingelheim announced today at the International Association for the Study of Lung Cancer"s 13th World Conference on Lung Cancer (WCLC), San Francisco, CA, the initiation of a Phase III clinical study of BIBW 2992 as first-line treatment in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations. BIBW 2992 (planned brand name Tovok™) is the first orally-administered, irreversible dual inhibitor of EGFR and HER2,1 to reach Phase III development in NSCLC.2
generic viagra online
BUPA Launches Breakthrough Treatment For Back And Knee Pain
New research reveals around 22 million people suffered back pain in the last year - just under half of all UK adults (45 percent)[1]. More than one in four UK adults - nearly 13 million people - suffered from knee pain in the last year. Over 80 percent of the people with back or knee pain still suffer some pain after undergoing treatment recommended by a healthcare professional. Bupa is making APOS Treatment for knee and lower back pain available in the UK for the first time. The breakthrough treatment can eliminate the need for prescription pain relief for seven out of 10 people[2].
News of the day
News Examines Lawmakers' Contributions In Health Reform Debate
Over the last 27 sessions of Congress, there has always been a Dingell universal health care bill, introduced first by Rep. John D. Dingell"s father during World War II, and then by his son, The Washington Times reports.
Oncology

Godel Technologies Europe Helps NHS Save Lives With Online Training Technology, UK

Manchester based software engineering company, Godel Technologies Europe Ltd, is to implement a virtual learning portal for the NHS. The online system will help NHS employees from across the country to receive high quality Masters training whilst continuing their professional careers by studying at their own convenience. Aimed specifically at health care professionals working in the field of major incident response, the new Masters course, MSc Health Incident Command, is being organised by the University Hospital of South Manchester NHS Foundation Trust (UHSM), in collaboration with Manchester Metropolitan University and the Department of Health. Terry Bland, managing director of Godel Technologies commented: "We are delighted to have been involved in such a worthwhile project. Using virtual learning environment technology enables a national rollout of on - the - job training for this new qualification. Paramedics and doctors from any location can complete the course, receiving fantastic training that fits in with their busy professional careers. Ultimately, by enabling widespread high level learning, the online portal will help the NHS to save more lives." Godel, who specialise in NHS contracts won this latest project after completing a similar Sharepoint intranet portal, which was used to train staff at UHSM. Dr David Macklin, educational research fellow at UHSM commented: "We have a good long term working relationship with Godel Technologies and it is fantastic to see that their systems will, yet again, be able to support the NHS" educational needs. The virtual learning environment implemented by Godel will enable health care professionals working in the field of major incident response to take part in this Masters level programme whilst continuing their normal work, which will be of great benefit to the NHS." Godel Technologies


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009